Clinical Trial Update: Ramosetron, Aprepitant, and Dexamethasone Versus Palonosetron, Aprepitant, and Dexamethasone [Phase 4]

View source ↗

Summary

This Phase 4 trial compares Ramosetron, Aprepitant, and Dexamethasone against Palonosetron, Aprepitant, and Dexamethasone for prevention of chemotherapy-induced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Aprepitant (aprepitant)
• DEXAMETHASONE (Dexamethasone)
• Palonosetron (palonosetron)
• Ramosetron (ramosetron)

Snippet

Sponsor: Kangdong Sacred Heart Hospital | Conditions: Cancer, Tumors | Phase 4 | Status: COMPLETED